1136 The differential expression of LIMA1/EPLIN in normal and cervical cancer tissues Article Swipe

PDF

E Kalafati , Ekati Drakopoulou , Nicholas P. Anagnou , Kalliopi I. Pappa ·

YOU? · · 2021 · Open Access · · DOI: https://doi.org/10.1136/ijgc-2021-esgo.95

Introduction/Background* LIMA1 or EPLIN is a cytoskeleton-associated protein involved in cytoskeleton regulation and dynamics, by inhibiting actin filament depolymerization and cross-linking filaments. The role of LIMA1 has been investigated in several malignant diseases including prostate, esophageal, breast and ovarian cancer. Its expression is often lost or aberrant in tumor cells leading to aggressive phenotypes. The aim of this study was to systematically assess the expression of LIMA1 in cervical cancer. Methodology Immunohistochemical analysis using anti-EPLIN antibody was performed in 22 cases of cervical intraepithelial neoplasia, 14 cases of adenocarcinoma including one case with mucinous and one case with endometrioid adenocarcinoma, 5 cases of adenosquamous carcinoma, 25 cases of squamous cell carcinoma and 11 normal samples. The correlation of LIMA1 aberrant expression and disease progression was performed using the medical records of patients. Clinical samples of normal and tumor tissues were surgically excised, following an informed consent from all participants. Result(s)* The levels of LIMA1 expression were low for healthy specimens, and limited to the cells of the basal membrane. LIMA1 expression showed a slight increase in the cases of intraepithelial neoplasia; however, it was quite low in cells displaying a HPV cytopathic effect (koilocytosis). On the contrary, the LIMA1 levels of both cytoplasmic and cell-membrane staining were significantly increased in the cases of adenocarcinoma and squamous cell carcinoma. Lastly, LIMA1 was highly expressed in undifferentiated, non-keratinizing, squamous cell carcinoma associated with poor prognosis. Conclusion* Our results demonstrate that LIMA1 is differentially expressed not only in normal and cervical cancer tissues, but also in precancerous lesions and malignant cervical neoplasia, highlighting its role in cervical cancer progression and its potential exploitation as a prognostic factor.

Related Topics

Concepts

Adenosquamous carcinoma Pathology Immunohistochemistry Adenocarcinoma Cancer Cancer research Carcinoma Vimentin Biology Medicine Internal medicine

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1136/ijgc-2021-esgo.95
PDF: https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A64.2.full.pdf
OA Status: bronze
Cited By: 1
Related Works: 10
OpenAlex ID: https://openalex.org/W3207573768

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W3207573768

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1136/ijgc-2021-esgo.95

Digital Object Identifier
Title: 1136 The differential expression of LIMA1/EPLIN in normal and cervical cancer tissues

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2021

Year of publication
Publication date: 2021-10-01

Full publication date if available
Authors: E Kalafati, Ekati Drakopoulou, Nicholas P. Anagnou, Kalliopi I. Pappa

List of authors in order
Landing page: https://doi.org/10.1136/ijgc-2021-esgo.95

Publisher landing page
PDF URL: https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A64.2.full.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A64.2.full.pdf

Direct OA link when available
Concepts: Adenosquamous carcinoma, Pathology, Immunohistochemistry, Adenocarcinoma, Cancer, Cancer research, Carcinoma, Vimentin, Biology, Medicine, Internal medicine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 1

Total citation count in OpenAlex
Citations by year (recent): 2025: 1

Per-year citation counts (last 5 years)
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W3207573768
doi	https://doi.org/10.1136/ijgc-2021-esgo.95
ids.doi	https://doi.org/10.1136/ijgc-2021-esgo.95
ids.mag	3207573768
ids.openalex	https://openalex.org/W3207573768
fwci	0.0
type	article
title	1136 The differential expression of LIMA1/EPLIN in normal and cervical cancer tissues
biblio.issue
biblio.volume
biblio.last_page	A64
biblio.first_page	A64.2
topics[0].id	https://openalex.org/T11482
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9332000017166138
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1312
topics[0].subfield.display_name	Molecular Biology
topics[0].display_name	RNA modifications and cancer
topics[1].id	https://openalex.org/T13157
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.9157999753952026
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1312
topics[1].subfield.display_name	Molecular Biology
topics[1].display_name	Cancer-related gene regulation
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2776512503
concepts[0].level	4
concepts[0].score	0.6760789752006531
concepts[0].wikidata	https://www.wikidata.org/wiki/Q3658380
concepts[0].display_name	Adenosquamous carcinoma
concepts[1].id	https://openalex.org/C142724271
concepts[1].level	1
concepts[1].score	0.6028655767440796
concepts[1].wikidata	https://www.wikidata.org/wiki/Q7208
concepts[1].display_name	Pathology
concepts[2].id	https://openalex.org/C204232928
concepts[2].level	2
concepts[2].score	0.5297514200210571
concepts[2].wikidata	https://www.wikidata.org/wiki/Q899285
concepts[2].display_name	Immunohistochemistry
concepts[3].id	https://openalex.org/C2781182431
concepts[3].level	3
concepts[3].score	0.4996912479400635
concepts[3].wikidata	https://www.wikidata.org/wiki/Q356033
concepts[3].display_name	Adenocarcinoma
concepts[4].id	https://openalex.org/C121608353
concepts[4].level	2
concepts[4].score	0.4776560068130493
concepts[4].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[4].display_name	Cancer
concepts[5].id	https://openalex.org/C502942594
concepts[5].level	1
concepts[5].score	0.44750815629959106
concepts[5].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[5].display_name	Cancer research
concepts[6].id	https://openalex.org/C2777546739
concepts[6].level	2
concepts[6].score	0.43906962871551514
concepts[6].wikidata	https://www.wikidata.org/wiki/Q33525
concepts[6].display_name	Carcinoma
concepts[7].id	https://openalex.org/C147447768
concepts[7].level	3
concepts[7].score	0.4365770220756531
concepts[7].wikidata	https://www.wikidata.org/wiki/Q411624
concepts[7].display_name	Vimentin
concepts[8].id	https://openalex.org/C86803240
concepts[8].level	0
concepts[8].score	0.4296495020389557
concepts[8].wikidata	https://www.wikidata.org/wiki/Q420
concepts[8].display_name	Biology
concepts[9].id	https://openalex.org/C71924100
concepts[9].level	0
concepts[9].score	0.39982104301452637
concepts[9].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[9].display_name	Medicine
concepts[10].id	https://openalex.org/C126322002
concepts[10].level	1
concepts[10].score	0.24992498755455017
concepts[10].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[10].display_name	Internal medicine
keywords[0].id	https://openalex.org/keywords/adenosquamous-carcinoma
keywords[0].score	0.6760789752006531
keywords[0].display_name	Adenosquamous carcinoma
keywords[1].id	https://openalex.org/keywords/pathology
keywords[1].score	0.6028655767440796
keywords[1].display_name	Pathology
keywords[2].id	https://openalex.org/keywords/immunohistochemistry
keywords[2].score	0.5297514200210571
keywords[2].display_name	Immunohistochemistry
keywords[3].id	https://openalex.org/keywords/adenocarcinoma
keywords[3].score	0.4996912479400635
keywords[3].display_name	Adenocarcinoma
keywords[4].id	https://openalex.org/keywords/cancer
keywords[4].score	0.4776560068130493
keywords[4].display_name	Cancer
keywords[5].id	https://openalex.org/keywords/cancer-research
keywords[5].score	0.44750815629959106
keywords[5].display_name	Cancer research
keywords[6].id	https://openalex.org/keywords/carcinoma
keywords[6].score	0.43906962871551514
keywords[6].display_name	Carcinoma
keywords[7].id	https://openalex.org/keywords/vimentin
keywords[7].score	0.4365770220756531
keywords[7].display_name	Vimentin
keywords[8].id	https://openalex.org/keywords/biology
keywords[8].score	0.4296495020389557
keywords[8].display_name	Biology
keywords[9].id	https://openalex.org/keywords/medicine
keywords[9].score	0.39982104301452637
keywords[9].display_name	Medicine
keywords[10].id	https://openalex.org/keywords/internal-medicine
keywords[10].score	0.24992498755455017
keywords[10].display_name	Internal medicine
language	en
locations[0].id	doi:10.1136/ijgc-2021-esgo.95
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4363605889
locations[0].source.issn
locations[0].source.type	conference
locations[0].source.is_oa	False
locations[0].source.issn_l
locations[0].source.is_core	False
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Cervical cancer
locations[0].source.host_organization
locations[0].source.host_organization_name
locations[0].license
locations[0].pdf_url	https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A64.2.full.pdf
locations[0].version	publishedVersion
locations[0].raw_type	proceedings-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Cervical cancer
locations[0].landing_page_url	https://doi.org/10.1136/ijgc-2021-esgo.95
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5035972904
authorships[0].author.orcid
authorships[0].author.display_name	E Kalafati
authorships[0].countries	GR
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210093138
authorships[0].affiliations[0].raw_affiliation_string	Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
authorships[0].institutions[0].id	https://openalex.org/I4210093138
authorships[0].institutions[0].ror	https://ror.org/00gban551
authorships[0].institutions[0].type	nonprofit
authorships[0].institutions[0].lineage	https://openalex.org/I4210093138
authorships[0].institutions[0].country_code	GR
authorships[0].institutions[0].display_name	Biomedical Research Foundation of the Academy of Athens
authorships[0].author_position	first
authorships[0].raw_author_name	E Kalafati
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
authorships[1].author.id	https://openalex.org/A5016713881
authorships[1].author.orcid	https://orcid.org/0000-0001-6246-3885
authorships[1].author.display_name	Ekati Drakopoulou
authorships[1].countries	GR
authorships[1].affiliations[0].institution_ids	https://openalex.org/I4210093138
authorships[1].affiliations[0].raw_affiliation_string	Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
authorships[1].institutions[0].id	https://openalex.org/I4210093138
authorships[1].institutions[0].ror	https://ror.org/00gban551
authorships[1].institutions[0].type	nonprofit
authorships[1].institutions[0].lineage	https://openalex.org/I4210093138
authorships[1].institutions[0].country_code	GR
authorships[1].institutions[0].display_name	Biomedical Research Foundation of the Academy of Athens
authorships[1].author_position	middle
authorships[1].raw_author_name	E Drakopoulou
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
authorships[2].author.id	https://openalex.org/A5028975699
authorships[2].author.orcid	https://orcid.org/0000-0001-7130-5192
authorships[2].author.display_name	Nicholas P. Anagnou
authorships[2].countries	GR
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210093138
authorships[2].affiliations[0].raw_affiliation_string	Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
authorships[2].institutions[0].id	https://openalex.org/I4210093138
authorships[2].institutions[0].ror	https://ror.org/00gban551
authorships[2].institutions[0].type	nonprofit
authorships[2].institutions[0].lineage	https://openalex.org/I4210093138
authorships[2].institutions[0].country_code	GR
authorships[2].institutions[0].display_name	Biomedical Research Foundation of the Academy of Athens
authorships[2].author_position	middle
authorships[2].raw_author_name	N Anagnou
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
authorships[3].author.id	https://openalex.org/A5055159801
authorships[3].author.orcid	https://orcid.org/0000-0002-1061-7405
authorships[3].author.display_name	Kalliopi I. Pappa
authorships[3].countries	GR
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210093138
authorships[3].affiliations[0].raw_affiliation_string	Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece;
authorships[3].institutions[0].id	https://openalex.org/I4210093138
authorships[3].institutions[0].ror	https://ror.org/00gban551
authorships[3].institutions[0].type	nonprofit
authorships[3].institutions[0].lineage	https://openalex.org/I4210093138
authorships[3].institutions[0].country_code	GR
authorships[3].institutions[0].display_name	Biomedical Research Foundation of the Academy of Athens
authorships[3].author_position	last
authorships[3].raw_author_name	K Pappa
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece;
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A64.2.full.pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	1136 The differential expression of LIMA1/EPLIN in normal and cervical cancer tissues
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11482
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9332000017166138
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1312
primary_topic.subfield.display_name	Molecular Biology
primary_topic.display_name	RNA modifications and cancer
related_works	https://openalex.org/W2038032297, https://openalex.org/W189082278, https://openalex.org/W2018380129, https://openalex.org/W2127954959, https://openalex.org/W2395191958, https://openalex.org/W2055460663, https://openalex.org/W2475257193, https://openalex.org/W2322682540, https://openalex.org/W2391474493, https://openalex.org/W2380903916
cited_by_count	1
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	1
locations_count	1
best_oa_location.id	doi:10.1136/ijgc-2021-esgo.95
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4363605889
best_oa_location.source.issn
best_oa_location.source.type	conference
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Cervical cancer
best_oa_location.source.host_organization
best_oa_location.source.host_organization_name
best_oa_location.license
best_oa_location.pdf_url	https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A64.2.full.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	proceedings-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Cervical cancer
best_oa_location.landing_page_url	https://doi.org/10.1136/ijgc-2021-esgo.95
primary_location.id	doi:10.1136/ijgc-2021-esgo.95
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4363605889
primary_location.source.issn
primary_location.source.type	conference
primary_location.source.is_oa	False
primary_location.source.issn_l
primary_location.source.is_core	False
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Cervical cancer
primary_location.source.host_organization
primary_location.source.host_organization_name
primary_location.license
primary_location.pdf_url	https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A64.2.full.pdf
primary_location.version	publishedVersion
primary_location.raw_type	proceedings-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Cervical cancer
primary_location.landing_page_url	https://doi.org/10.1136/ijgc-2021-esgo.95
publication_date	2021-10-01
publication_year	2021
referenced_works_count	0
abstract_inverted_index.5	100
abstract_inverted_index.a	5, 172, 189, 271
abstract_inverted_index.11	112
abstract_inverted_index.14	85
abstract_inverted_index.22	79
abstract_inverted_index.25	105
abstract_inverted_index.On	194
abstract_inverted_index.an	143
abstract_inverted_index.as	270
abstract_inverted_index.by	14
abstract_inverted_index.in	9, 29, 47, 67, 78, 175, 186, 209, 223, 244, 252, 262
abstract_inverted_index.is	4, 42, 239
abstract_inverted_index.it	182
abstract_inverted_index.of	24, 56, 65, 81, 87, 102, 107, 117, 130, 134, 152, 165, 178, 200, 212
abstract_inverted_index.or	2, 45
abstract_inverted_index.to	51, 60, 162
abstract_inverted_index.HPV	190
abstract_inverted_index.Its	40
abstract_inverted_index.Our	234
abstract_inverted_index.The	22, 54, 115, 150
abstract_inverted_index.aim	55
abstract_inverted_index.all	147
abstract_inverted_index.and	12, 19, 37, 94, 111, 121, 136, 160, 203, 214, 246, 255, 266
abstract_inverted_index.but	250
abstract_inverted_index.for	157
abstract_inverted_index.has	26
abstract_inverted_index.its	260, 267
abstract_inverted_index.low	156, 185
abstract_inverted_index.not	242
abstract_inverted_index.one	90, 95
abstract_inverted_index.the	63, 127, 163, 166, 176, 195, 197, 210
abstract_inverted_index.was	59, 76, 124, 183, 220
abstract_inverted_index.also	251
abstract_inverted_index.been	27
abstract_inverted_index.both	201
abstract_inverted_index.case	91, 96
abstract_inverted_index.cell	109, 216, 227
abstract_inverted_index.from	146
abstract_inverted_index.lost	44
abstract_inverted_index.only	243
abstract_inverted_index.poor	231
abstract_inverted_index.role	23, 261
abstract_inverted_index.that	237
abstract_inverted_index.this	57
abstract_inverted_index.were	139, 155, 206
abstract_inverted_index.with	92, 97, 230
abstract_inverted_index.EPLIN	3
abstract_inverted_index.LIMA1	1, 25, 66, 118, 153, 169, 198, 219, 238
abstract_inverted_index.actin	16
abstract_inverted_index.basal	167
abstract_inverted_index.cases	80, 86, 101, 106, 177, 211
abstract_inverted_index.cells	49, 164, 187
abstract_inverted_index.often	43
abstract_inverted_index.quite	184
abstract_inverted_index.study	58
abstract_inverted_index.tumor	48, 137
abstract_inverted_index.using	73, 126
abstract_inverted_index.assess	62
abstract_inverted_index.breast	36
abstract_inverted_index.cancer	248, 264
abstract_inverted_index.effect	192
abstract_inverted_index.highly	221
abstract_inverted_index.levels	151, 199
abstract_inverted_index.normal	113, 135, 245
abstract_inverted_index.showed	171
abstract_inverted_index.slight	173
abstract_inverted_index.Lastly,	218
abstract_inverted_index.cancer.	39, 69
abstract_inverted_index.consent	145
abstract_inverted_index.disease	122
abstract_inverted_index.factor.	273
abstract_inverted_index.healthy	158
abstract_inverted_index.leading	50
abstract_inverted_index.lesions	254
abstract_inverted_index.limited	161
abstract_inverted_index.medical	128
abstract_inverted_index.ovarian	38
abstract_inverted_index.protein	7
abstract_inverted_index.records	129
abstract_inverted_index.results	235
abstract_inverted_index.samples	133
abstract_inverted_index.several	30
abstract_inverted_index.tissues	138
abstract_inverted_index.Clinical	132
abstract_inverted_index.aberrant	46, 119
abstract_inverted_index.analysis	72
abstract_inverted_index.antibody	75
abstract_inverted_index.cervical	68, 82, 247, 257, 263
abstract_inverted_index.diseases	32
abstract_inverted_index.excised,	141
abstract_inverted_index.filament	17
abstract_inverted_index.however,	181
abstract_inverted_index.increase	174
abstract_inverted_index.informed	144
abstract_inverted_index.involved	8
abstract_inverted_index.mucinous	93
abstract_inverted_index.samples.	114
abstract_inverted_index.squamous	108, 215, 226
abstract_inverted_index.staining	205
abstract_inverted_index.tissues,	249
abstract_inverted_index.carcinoma	110, 228
abstract_inverted_index.contrary,	196
abstract_inverted_index.dynamics,	13
abstract_inverted_index.expressed	222, 241
abstract_inverted_index.following	142
abstract_inverted_index.including	33, 89
abstract_inverted_index.increased	208
abstract_inverted_index.malignant	31, 256
abstract_inverted_index.membrane.	168
abstract_inverted_index.patients.	131
abstract_inverted_index.performed	77, 125
abstract_inverted_index.potential	268
abstract_inverted_index.prostate,	34
abstract_inverted_index.aggressive	52
abstract_inverted_index.anti-EPLIN	74
abstract_inverted_index.associated	229
abstract_inverted_index.carcinoma,	104
abstract_inverted_index.carcinoma.	217
abstract_inverted_index.cytopathic	191
abstract_inverted_index.displaying	188
abstract_inverted_index.expression	41, 64, 120, 154, 170
abstract_inverted_index.filaments.	21
abstract_inverted_index.inhibiting	15
abstract_inverted_index.neoplasia,	84, 258
abstract_inverted_index.neoplasia;	180
abstract_inverted_index.prognosis.	232
abstract_inverted_index.prognostic	272
abstract_inverted_index.regulation	11
abstract_inverted_index.specimens,	159
abstract_inverted_index.surgically	140
abstract_inverted_index.correlation	116
abstract_inverted_index.cytoplasmic	202
abstract_inverted_index.demonstrate	236
abstract_inverted_index.esophageal,	35
abstract_inverted_index.phenotypes.	53
abstract_inverted_index.progression	123, 265
abstract_inverted_index.cytoskeleton	10
abstract_inverted_index.endometrioid	98
abstract_inverted_index.exploitation	269
abstract_inverted_index.highlighting	259
abstract_inverted_index.investigated	28
abstract_inverted_index.precancerous	253
abstract_inverted_index.adenosquamous	103
abstract_inverted_index.cell-membrane	204
abstract_inverted_index.cross-linking	20
abstract_inverted_index.participants.	148
abstract_inverted_index.significantly	207
abstract_inverted_index.adenocarcinoma	88, 213
abstract_inverted_index.differentially	240
abstract_inverted_index.systematically	61
abstract_inverted_index.(koilocytosis).	193
abstract_inverted_index.adenocarcinoma,	99
abstract_inverted_index.intraepithelial	83, 179
abstract_inverted_index.depolymerization	18
abstract_inverted_index.non-keratinizing,	225
abstract_inverted_index.undifferentiated,	224
abstract_inverted_index.<h3>Result(s)*</h3>	149
abstract_inverted_index.Immunohistochemical	71
abstract_inverted_index.<h3>Conclusion*</h3>	233
abstract_inverted_index.<h3>Methodology</h3>	70
abstract_inverted_index.cytoskeleton-associated	6
abstract_inverted_index.<h3>Introduction/Background*</h3>	0
cited_by_percentile_year.max	95
cited_by_percentile_year.min	91
countries_distinct_count	1
institutions_distinct_count	4
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.7699999809265137
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.15848007
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False